Concepedia

Author

R W Klecker

National Cancer Institute

Also Known As

R Klecker, R W Klecker, R. Klecker, R. W. KLECKER*, RaymondW. Klecker

14

Publications

1.7K

Citations

11

H-Index

42

Concepts

All Affiliations

National Cancer InstituteUnited States Food and Drug AdministrationCenter for Drug Evaluation and Research
RW

About

R W Klecker is an author at National Cancer Institute specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

1.4K

2

Health Sciences

4

4

545

3

Immunology

3

3

859

4

Biochemistry

2

2

96

5

Hepatology

1

1

63

R W Klecker

×

11

Publications

1.7K

Citations

11

H-Index

YearCitations

ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

Robert Yarchoan, KentJ. Weinhold, H. Kim Lyerly,

The Lancet

1986

803

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

Robert F. Ozols, Robert E. Cunnion, R W Klecker,

Journal of Clinical Oncology

1987

426

Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme.

Timothy J. Kinsella, Jerry M. Collins, J. Mark Rowland,

Journal of Clinical Oncology

1988

96

Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.

Wyndham H. Wilson, Carlos Jamis‐Dow, G Bryant,

Journal of Clinical Oncology

1995

91

Rifampin and rifabutin and their metabolism by human liver esterases

Carlos Jamis‐Dow, Aspandiar G. Katki, Jerry M. Collins,

Xenobiotica

1997

63

Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid.

Jerry M. Collins, R W Klecker, James A. Kelley,

Journal of Pharmacology and Experimental Therapeutics

1988

54

Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells.

R W Klecker, Aspandiar G. Katki, Jessica M. Collins

Molecular Pharmacology

1994

39

Metabolism of rifabutin and its 25-desacetyl metabolite, LM565, by human liver microsomes and recombinant human cytochrome P-450 3A4: relevance to clinical interaction with fluconazole

Carol Braun Trapnell, Carlos Jamis‐Dow, R W Klecker,

Antimicrobial Agents and Chemotherapy

1997

33

Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.

R W Klecker, Carlos Jamis‐Dow, Merrill J. Egorin,

Drug Metabolism and Disposition

1994

31

Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.

Christian Rohlff, Behnam Safa, Arshad Rahman,

Molecular Pharmacology

1993

27

Page 1